Meet Stelios Papadopoulos! The Greek (born in Thessaloniki, Greece) behind a new FDA approved wonder drug that may finally give hope to an estimated 44 million people suffering from Alzheimer’s disease worldwide.
Stelios stated that the new drug will be for those in the early on set stages of Alzheimers and to those who’s PET scan showed they had the amyloid plaque in their brain. The drug will not be intended for those in the late stage of the debilitating disease. The drug will not stop or accelerate the progress of Alzheimers, but will slow the progress of the disease, says Papadopoulos in the video interview.
Stelios is CEO of Biogen. The drug company was founded in 1978, a pioneer in the field of neuroscience, the company has been producing therapies for MS, Alzheimer’s, Parkinson’s and ALS. Biogen obtained FDA approval in June 2021 for the new Alzheimers medicine that has the potential to improve the lives of Alzheimer’s sufferers around the world. People lose their memory and capacity to care for themselves as the debilitating disease progresses. The company was founded in 1978, a pioneer in the field of neuroscience, the company has been producing therapies for MS, Alzheimer’s, Parkinson’s and ALS.
Stelios moved to the United States for a better and brighter future. He has been with the company for just less than 20 years. Stelios is 72 and lives in New York. He has been called the “father of biogenetics” by CNN and Bloomberg. Sitting at the top of a company valued at almost $15B, he has many degrees in Math, Physics and Business. He loved soccer as a teen and was a student of electrical engineering at Athens Technical University, Metsovio.
Papadopoulos explains “Greeks are a migratory people…we are missing a connection to our heritage, to our language, as we find our way in the world. Initiatives that bind Greeks with their heritage are superb.”
Papadopoulos mother told him: “If you want to go to America, son, that is where your future is and that is where you should go.” His mother is 92 today and thriving. Stelios stated they have good DNA and it looks like his family will not be affected with Alzheimer’s. He added he still has aunts and uncles who are 80 and older.
